Accepted for/Published in: JMIR Research Protocols
Date Submitted: Dec 12, 2024
Open Peer Review Period: Dec 16, 2024 - Feb 10, 2025
Date Accepted: Jul 9, 2025
(closed for review but you can still tweet)
Assessing a person-centered and culturally sensitive intervention for type 2 diabetes in individuals with for Arabic-, Turkish-, or Urdu-speaking individual with type 2 diabetes: A mixed-methods realist evaluation protocol for the ACCT2 study
ABSTRACT
Background:
People from ethnic minority backgrounds have a 2.5 times higher incidence of type 2 diabetes than ethnic Danes. They often face negative experiences with healthcare professionals, leading to mistrust and unequal treatment due to diverse health perceptions. A person-centred, culturally adapted approach focusing on knowledge, motivation, culture, beliefs, and socioeconomic support can improve self-care, diabetes management, and treatment adherence among persons from ethnic minority backgrounds.
Objective:
This mixed-methods realist evaluation protocol aims to understand how a person-centred and culturally sensitive course of treatment in individuals with type 2 diabetes and non-Western Backgrounds (The ACCT2 study) works.
Methods:
This study, embedded within a randomised controlled trial, the ACCT2 study, utilises a realist evaluation to assess what works, for whom it is most effective, and under what circumstances it is likely to be effective, alongside the causal effectiveness examined in the RCT. Our realist evaluation follows three phases: 1) Developing, 2) Testing, and 3) Refining initial program theories. Data will be collected through semi-structured interviews and survey data. A thematic analysis guided by a predefined codebook based on our initial program theories will be conducted.
Results:
As of December 2024, 13 participants have been enrolled, with 13 V4 interviews completed. Data analysis is pending. The results will inform revisions to the initial program theories, refining a comprehensive model that accurately captures the interactions between context, mechanisms, and outcomes in the ACCT2 study. We anticipate disseminating the findings in the first half of 2026.
Conclusions:
This RE is expected to support the RCT by offering insights applicable to real-life clinical settings. The anticipated impact includes aiding the future development and implementation of interventions for persons with ethnic minority backgrounds and T2D. Clinical Trial: This study is registered as a component of the ACCT2 study (ID: NCT06147245)
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.